Surgical strategy for huge and advanced hepatocellular carcinoma in Hong Kong

Kenneth S.H. Chok

Hepatoma Research ›› 2017, Vol. 3 : 189 -95.

PDF
Hepatoma Research ›› 2017, Vol. 3:189 -95. DOI: 10.20517/2394-5079.2017.33
Review
Review

Surgical strategy for huge and advanced hepatocellular carcinoma in Hong Kong

Author information +
History +
PDF

Abstract

In Hong Kong, surgical resection is the core curative treatment for huge and advanced hepatocellular carcinoma (HCC). For tumors measuring 10 cm or above, major hepatectomy is usually required, but a future liver remnant not large enough will preclude the operation. Hypertrophy of future liver remnant is a way to render more patients operable, and measures include portal vein embolization and associating liver partition and portal vein ligation for staged hepatectomy. For HCC that has invaded a major vessel, en bloc resection with immediate vessel reconstruction is necessary if thrombectomy would not suffice. In case of bilobar involvement, radiofrequency ablation is a useful adjuctive therapy. In the treatment of extrahepatic metastasis, metastasectomy offers a cure to properly selected patients.

Keywords

Associating liver partition and portal vein ligation / staged hepatectomy / hepatocellular carcinoma / liver resection / vascular resection and reconstruction / radiofrequency ablation

Cite this article

Download citation ▾
Kenneth S.H. Chok. Surgical strategy for huge and advanced hepatocellular carcinoma in Hong Kong. Hepatoma Research, 2017, 3: 189-95 DOI:10.20517/2394-5079.2017.33

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kim DY.Epidemiology and surveillance of hepatocellular carcinoma..Liver Cancer2012;1:2-14 PMCID:PMC3747543

[2]

Ferlay J,Bray F,Mathers C.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008..Int J Cancer2010;127:2893-917

[3]

Fan ST,Yeung C,Lo CM,Ng KK,Chan SC.Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria..Br J Surg2011;98:1292-300

[4]

Llovet JM,Bruix J.Prognosis of hepatocellular carcinoma: the BCLC staging classification..Semin Liver Dis1999;19:329-38

[5]

Bruix J.Prognostic prediction and treatment strategy in hepatocellular carcinoma..Hepatology2002;35:519-24

[6]

Llovet JM,Bruix J.Hepatocellular carcinoma..Lancet2003;362:1907-17

[7]

Forner A,de Lope CR.Current strategy for staging and treatment: the BCLC update and future prospects..Semin Liver Dis2010;30:61-74

[8]

Yau T,Yao TJ,Lo CM.Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma..Gastroenterology2014;146:1691-700.e3

[9]

Fan ST,Poon RT,Leung Liu C,Ming Lam C,Ching Chan S.Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience..Ann Surg2011;253:745-58

[10]

Cauchy F,Belghiti J.Liver resection for HCC: patient's selection and controversial scenarios..Best Pract Res Clin Gastroenterol2014;28:881-96

[11]

Poon RT.Assessment of hepatic reserve for indication of hepatic resection: how I do it..J Hepatobiliary Pancreat Surg2005;12:31-7

[12]

Liu CL,Cheung ST,Ng IO.Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study..Ann Surg2006;244:194-203 PMCID:PMC1602174

[13]

Melendez JA,Fischer ME,Jarnagin WR,Blumgart LH.Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction..J Am Coll Surg1998;187:620-5

[14]

Fan ST,Lo CM,Wong J.Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis..Arch Surg1995;130:198-203

[15]

Poon RT,Lo CM,Lam CM,Yeung C.Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?.Ann Surg2002;236:602-11

[16]

Fan ST,Liu CL,Yuen WK,Wong J.Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths..Ann Surg1999;229:322-30 PMCID:PMC1191696

[17]

Lau H,Fan ST,Lo CM.Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy..Br J Surg1997;84:1255-9

[18]

Fan ST.Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective..J Hepatobiliary Pancreat Surg2010;17:380-4

[19]

Heymsfield SB,Nordlinger B,Sones P.Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography..Ann Intern Med1979;90:185-7

[20]

Chan SC,Chok KS,Cheung TT,Chan AC.Validation of graft and standard liver size predictions in right liver living donor liver transplantation..Hepatol Int2011;5:913-7 PMCID:PMC3215865

[21]

Urata K,Matsunami H,Ikegami T,Momose Y,Makuuchi M.Calculation of child and adult standard liver volume for liver transplantation..Hepatology1995;21:1317-21

[22]

Shoup M,D'Angelica M,DeMatteo RP,Tuorto S,Fong Y.Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection..J Gastrointest Surg2003;7:325-30

[23]

Vauthey JN,Do KA,Fenstermacher MJ,Hicks M,Lauwers G,Caridi J.Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations..Surgery2000;127:512-9

[24]

Kubota K,Kusaka K,Miki K,Harihara Y.Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors..Hepatology1997;26:1176-81

[25]

Shirabe K,Gion T,Takenaka K,Sugimachi K.Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume..J Am Coll Surg1999;188:304-9

[26]

Guglielmi A,Conci S,Iacono C.How much remnant is enough in liver resection?.Digest Surg2012;29:6-17

[27]

Schindl MJ,Fearon KC,Wigmore SJ.The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection..Gut2005;54:289-96 PMCID:PMC1774834

[28]

Kinoshita H,Hirohashi K,Yamasaki O.Preoperative portal vein embolization for hepatocellular carcinoma..World J Surg1986;10:803-8

[29]

Abulkhir A,Healey AJ,Tait P,Habib N.Preoperative portal vein embolization for major liver resection: a meta-analysis..Ann Surg2008;247:49-57

[30]

Heinrich S,Graf R.Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice..J Hepatol2006;45:35-42

[31]

Elias D,Roche A,Leclere J.During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma..Br J Surg1999;86:784-8

[32]

Kokudo N,Seki M,Azekura K,Ohta K,Matsubara T,Nakajima T,Ikari T,Kato Y.Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization..Hepatology2001;34:267-72

[33]

Schadde E,Robles-Campos R,Machado M,Soubrane O,Raptis D,Petrowsky H,Clavien PA.Early survival and safety of ALPPS: first report of the International ALPPS Registry..Ann Surg2014;260:829-38

[34]

Cavaness KM,Lin Y,Chapman WC.Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis..J Gastrointest Surg2013;17:207-12

[35]

Vennarecci G,Santoro R,Lepiane P.The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion..World J Surg2014;38:1498-503

[36]

Vennarecci G,Levi Sandri GB,Cristofaro M,Piselli P,D'Offizi G.The ALPPS procedure for hepatocellular carcinoma..Eur J Surg Oncol2014;40:982-8

[37]

Levi Sandri GB,Rayar M.ALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: a new opportunity?.J Hepatol2015;62:241-2

[38]

Baumgart J,Lang H.A new method for induction of liver hypertrophy prior to right trisectionectomy: a report of three cases..HPB (Oxford).2011;13:71-2

[39]

Chan AC,Poon RT.Simplifying the ALPPS procedure by the anterior approach..Ann Surg2014;260:e3

[40]

Schnitzbauer AA,Goessmann H,Baumgart J,Fichtner-Feigl S,Goralcyk A,Kroemer A,Rümmele P,Padberg W,Lang H,Schlitt HJ.Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings..Ann Surg2012;255:405-14

[41]

Schadde E,Slankamenac K,Sergeant G,Baumgart J,Hernandez-Alejandro R,de Santibaňes E.ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis..World J Surg2014;38:1510-9

[42]

Ielpo B,Vicente E.Pearls and pitfalls on ALPPS procedure: new complications in a new technique..Updates Surg2014;66:159-61

[43]

Nadalin S,Li J,Konigsrainer I.Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre..Z Gastroenterol2014;52:35-42

[44]

Knoefel WT,Rehders A,Krausch M,Fürst G.In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection..Br J Surg2013;100:388-94

[45]

Schadde E,Tschuor C,Bechstein WO.Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy..Ann Surg Oncol2015;22:3109-20

[46]

Wu CC,Chen JT,Lin MC,Liu TJ.An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation..Arch Surg2000;135:1273-9

[47]

Tanaka A,Yamaoka Y.Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein..Hepatogastroenterology1996;43:637-43

[48]

Chok KS,Chan SC,Fan ST.Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis..World J Surg2014;38:490-6

[49]

Chan SC,Lo CM,Poon RT,Fan ST.Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma..Arch Surg2003;138:265-71

[50]

Zhu K,Lai L,Zhou B,Cai M.Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib--a retrospective controlled study..Radiology2014;272:284-93

[51]

Ha Y,Shim JH,Lee HC,Lee YS,Ryu MH,Kang YK.Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma..Oncotarget2016;7:74303-13 PMCID:PMC5342054

[52]

Cheung TT,Chok KS,Poon RT,Fan ST.Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes..World J Gastroenterol2010;16:3056-62 PMCID:PMC2890947

[53]

Kishore S,Madoff DC.Update on embolization therapies for hepatocellular carcinoma..Curr Oncol Rep2017;19:40

[54]

Lee YT.Primary liver cancer: pattern of metastasis..J Surg Oncol1987;36:26-31

[55]

Chok KS,Cheung TT,Lo CM.Retrospective study of metachronous lung metastases from primary hepatocellular carcinoma..ANZ J Surg2016;86:289-93

PDF

157

Accesses

0

Citation

Detail

Sections
Recommended

/